Wells Fargo raised the firm’s price target on HCA Healthcare (HCA) to $400 from $395 and keeps an Equal Weight rating on the shares. Following Q3 earnings, the firm is updating models and detailed earnings bridges for each Hospital. Wells note that core revisions are for the most part relatively small, but there are impacts from Hurricane impacts and revised Medicaid supplemental payment assumptions that drive changes.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $400 from $390 at Oppenheimer
- HCA Healthcare price target lowered to $440 from $450 at TD Cowen
- HCA Healthcare price target lowered to $406 from $427 at Morgan Stanley
- HCA Healthcare price target lowered to $420 from $475 at KeyBanc
- Judge blocks Tapestry-Capri deal, Centene reports Q3 beat: Morning Buzz